The main risk is not whether the batteries work; it is whether Amprius can convert strong specs and visible orders into dependable, compliant, repeat shipments before
dilution, supplier dependence, or pricing pressure erode the edge. This is a scale-and-capture story: if outsourced production qualifies cleanly and defense pathways clear, value can compound fast; if not, the company risks staying a niche premium cell vendor with a valuation that outran its operating proof.